Patent · US Active

Pyridinone compounds

US8536200B2 · kind B2 · utility

5Cited by
8References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 8, 2010
Grant dateSep 17, 2013
Priority date
Expiry dateMar 21, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to pyridinone compounds useful for modulating Met kinase, having the following structure:and is further directed to pharmaceutical compositions comprising the compound; and methods for treating proliferative diseases, such as cancer by the administration of this compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.